Once we make the move to the Nasdaq we will have more coverage and institutions will probably take positions. I am hopeful that’s the first half of next year.
Third qtr institutional holdings data just came out for many pre revenue bios. No data on RVX but many of my other holdings have significant institutional presence. Those companies do have higher market cap.
I’m out of mainline stocks now and waiting to see if the market establishes a direction. This won’t affect my small biotechs. They are almost fully independent of the big caps.
News 
Market Data 
Discover 
